Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sage Therapeutic Com
(NQ:
SAGE
)
10.38
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sage Therapeutic Com
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Analyst Ratings For Sage Therapeutics
July 29, 2021
Analysts have provided the following ratings for Sage Therapeutics (NASDAQ:
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
August 04, 2021
Baird boosted the price target for Lululemon Athletica Inc. (NASDAQ:
Via
Benzinga
Sage Therapeutics Inc (SAGE) Q2 2021 Earnings Call Transcript
August 03, 2021
SAGE earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Sage Therapeutics Drops Two Zuranolone Depression Trials Deemed Unnecessary For Approval
August 03, 2021
Tucked in the Q2 earnings release, Sage Therapeutics Inc (NASDAQ: SAGE) has terminated two long-suspended Phase 3 zuranolone trials in major depressive disorder (MDD)....
Via
Benzinga
Sage Therapeutics: Q2 Earnings Insights
August 03, 2021
Shares of Sage Therapeutics (NASDAQ:SAGE) moved higher by 11.9% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 12...
Via
Benzinga
Sage Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
August 03, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
Stocks That Hit 52-Week Lows On Tuesday
August 03, 2021
On Tuesday morning, 69 companies achieved new lows for the year. Intriguing Points: Las Vegas Sands (NYSE:LVS) was the largest firm by market cap to set a new 52-...
Via
Benzinga
Sage Therapeutics to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
July 20, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For August 3, 2021
August 03, 2021
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 27, 2021
During Tuesday's morning session, 216 companies made new 52-week lows. Noteworthy Points: Alibaba Group Holding (NYSE:BABA) was the largest firm by market cap...
Via
Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
July 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...
Via
Benzinga
Sage Therapeutics to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
July 08, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
June’s Best and Worst Performing Russell 1,000 Stocks
June 29, 2021
The month of June, the second quarter and the first half of 2021 are almost in the bag.
Via
Talk Markets
How Bad Is Biogen's Latest Bad News?
June 29, 2021
The drugmaker has had one big clinical setback and another less serious disappointment in recent weeks.
Via
The Motley Fool
Sage Therapeutics to Participate in SVB Leerink’s 3rd Annual CNS Forum
June 24, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
What Happened to Sage Therapeutics Stock?
June 21, 2021
Sage has been struggling for some time to bring its flagship antidepressant to the market.
Via
The Motley Fool
Looking For Bargains Among The Rubble
June 20, 2021
Last week was tough. Nearly everything publicly traded took a hit. In this article I drill down into the market to take account of where the damage was the worst, and maybe identify a few bargains...
Via
Talk Markets
Here's Why Sage Therapeutics Tanked This Week
June 19, 2021
The neuroscience-focused biotech company didn't give investors the result they wanted.
Via
The Motley Fool
Biogen Discontinues Tau Antibody Program For Alzheimer's After Mid-Stage Study Flops
June 17, 2021
Biogen Inc (NASDAQ: BIIB) has four other Alzheimer’s candidates in its clinical pipeline behind recently-approved Aduhelm, of which one has just been canned. The...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2021
June 16, 2021
Upgrades According to Piper Sandler, the prior rating for First Bancorp (NASDAQ:
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
June 16, 2021
Morgan Stanley raised NIKE, Inc. (NYSE:NKE) price ta...
Via
Benzinga
44 Biggest Movers From Yesterday
June 16, 2021
Gainers Alzamend Neuro, Inc. (NASDAQ: ALZN) shares jumped 170% to close at $13.50 on Tuesday after the company priced its IPO at $5 per share. Alfi, Inc. (NASDAQ: ALF) shares...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Mid-Afternoon Market Update: Nasdaq Down 100 Points; Clearside Biomedical Shares Spike Higher
June 15, 2021
Toward the end of trading Tuesday, the Dow traded down 0.19% to 34,326.95 while the NASDAQ fell 0.70% to 14,074. The S&P also fell, dropping 0.12% to 4,249.99. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 15, 2021
Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 26.21% to $3.81 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...
Via
Benzinga
Here's Why Sage Therapeutics Stock Is Sliding Today
June 15, 2021
Long-awaited clinical trial results weren't as successful as hoped.
Via
The Motley Fool
Mid-Day Market Update: Crude Oil Rises 1%; Sage Therapeutics Shares Slide
June 15, 2021
Midway through trading Tuesday, the Dow traded down 0.45% to 34,238.18 while the NASDAQ fell 0.53% to 14,099.27. The S&P also fell, dropping 0.25% to 4,244.45. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
34 Stocks Moving In Tuesday's Mid-Day Session
June 15, 2021
Gainers HMG/Courtland Properties, Inc. (NYSE: HMG) shares surged 133% to $27.80. Alfi, Inc. (NASDAQ: ALF) shares jumped 82.1% to $6.21 after the company inked an agreement with...
Via
Benzinga
Biogen Analyst Raises Price Target On Higher Chance Of Success For Depression Drug
June 15, 2021
Biogen Inc. (NASDAQ: BIIB) stock is seeing muted sentiment Tuesday as it emerges from the euphoria over Aduhelm approval, with the most recent trigger being lukewarm data for a...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.